Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma: a Multicenter, Non-interventional, Retrospective Survey
Phase of Trial: Phase IV
Latest Information Update: 20 Jun 2013
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 15 Mar 2013 Actual initiation date (Nov 2007) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2011 New trial record